Neurocrine Biosciences (NBIX) Tops Q4 EPS by 12c
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $142.25 -1.19%
Revenue Growth %: +30.8%
Financial Fact:
Total revenues: 0
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +30.8%
Financial Fact:
Total revenues: 0
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q4 EPS of $1.24, $0.12 better than the analyst estimate of $1.12. Revenue for the quarter came in at $412 million versus the consensus estimate of $408.87 million.
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- AutoZone beats profit view but misses on revenue
- JPMorgan Downgrades Shenzhen Inovance Tech (300124:CH) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
